Novel autophagy inhibitor ESK981 potentiates MEK inhibition cytotoxicity in pancreatic cancer

被引：0
|
作者：
Cheng, Caleb
Wisniewski, Jasmine
Jackson, Bailey
Bao, Yi
Qiao, Yuanyuan
Lyssiotis, Costas A.
Chinnaiyan, Arul M.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1634
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1634
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preferential cytotoxicity of ESK981 in neuroendocrine prostate cancer
    Zheng, Yang
    Garcia-Rogers, Kyle J.
    Bao, Yi
    Mannan, Rahul
    He, Tongchen
    Yee, Sarah N.
    Cheng, Caleb
    Jiang, Xia
    Taylor, Isabella E.
    Cao, Xuhong
    Wang, Yuzhuo
    Qiao, Yuanyuan
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Phase II trial of multi-kinase inhibitor ESK981 in patients with metastatic castration-resistant prostate cancer
    Heath, Elisabeth I.
    Chen, Wei
    Heilbrun, Lance
    Choi, Jae E.
    Dobson, Kimberlee
    Smith, Melanie
    Maj, Tomasz
    Vaishampayan, Ulka
    Kryczek, Ilona
    Zou, Weiping
    Chinnaiyan, Arul M.
    Qiao, Yuanyuan
    INVESTIGATIONAL NEW DRUGS, 2024, : 566 - 574
  • [3] Combined inhibition of MEK and autophagy promotes regression of pancreatic cancer
    Kinsey, Conan
    Guillen, Katrin
    Camolotto, Soledad
    Boespflug, Amelie
    Shea, Jill
    Seipp, Michael
    Scaife, Courtney
    McMahon, Martin
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Phase II trial of multi-tyrosine kinase inhibitor ESK981 in combination with PD-1 inhibitor nivolumab in patients with metastatic castration-resistant prostate cancer
    Heath, Elisabeth I.
    Chen, Wei
    Choi, Jae E.
    Dobson, Kimberlee
    Smith, Melanie
    Maj, Tomasz
    Kryczek, Ilona
    Zou, Weiping
    Chinnaiyan, Arul M.
    Qiao, Yuanyuan
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (06) : 675 - 684
  • [5] Novel autophagy inhibitor to treat pancreatic cancer
    Ramachandran, Mythili
    Ma, Zhao
    Li, Yuanpei
    CANCER RESEARCH, 2021, 81 (13)
  • [6] MEK Inhibition Potentiates the Activity of Hsp90 Inhibitor 17-AAG against Pancreatic Cancer Cells
    Zhang, Tao
    Li, Yanyan
    Zhu, Zhenkun
    Gu, Mancang
    Newman, Bryan
    Sun, Duxin
    MOLECULAR PHARMACEUTICS, 2010, 7 (05) : 1576 - 1584
  • [7] Autophagy inhibition potentiates oxaliplatin cytotoxicity in hypoxic colon cancer cell lines in vitro and in vivo
    Selvakumaran, Muthu
    Vasilevskaya, Irina
    Amaravadi, Ravi
    O'Dwyer, Peter
    CANCER RESEARCH, 2009, 69
  • [8] Inhibition of autophagy potentiates cytotoxicity of CX-5461 treatment in chemoresistant epithelial ovarian cancer
    Cornelison, Robert
    Llaneza, Danielle C.
    Petrova, Yulia
    Dobbin, Zachary C.
    Schneider, David A.
    Landen, Charles N.
    CANCER RESEARCH, 2017, 77
  • [9] Inhibition of CCR2 potentiates the checkpoint inhibitor immunotherapy in pancreatic cancer
    Jung, Heiyoun
    Ertl, Linda
    Janson, Christine
    Schall, Thomas
    Charo, Israel
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [10] Protective autophagy elicited by RAF®MEK®ERK inhibition suggests a treatment strategy for pancreatic cancer
    Kinsey, Conan G.
    Camolotto, Soledad A.
    Boespflug, Amelie M.
    Guillen, Katrin P.
    Foth, Mona
    Truong, Amanda
    Schuman, Sophia S.
    Shea, Jill E.
    Seipp, Michael T.
    Yap, Jeffrey T.
    Burrell, Lance D.
    Lum, David H.
    Whisenant, Jonathan R.
    Gilcrease, G. Weldon
    Cavalieri, Courtney C.
    Rehbein, Kaitrin M.
    Cutler, Stephanie L.
    Affolter, Kajsa E.
    Welm, Alana L.
    Welm, Bryan E.
    Scaife, Courtney L.
    Snyder, Eric L.
    McMahon, Martin
    CANCER RESEARCH, 2019, 79 (13)
12345